Lonza to Acquire Five US Manufacturing Sites from Merck in Major Expansion
Swiss contract drug manufacturer Lonza announced on Tuesday that it would acquire five US manufacturing sites from Germany’s Merck KGaA, significantly expanding its presence in the country and strengthening its capabilities in producing advanced...
FDA Panel to Review Moderna’s Flu Vaccine for Older Adults
The U.S. Food and Drug Administration’s (FDA) independent vaccine advisory panel is set to review and vote on whether the benefits of Moderna’s influenza vaccine, mFlusiva, outweigh its potential risks in older adults. Moderna...
Apotex Health Targets Up to C$1.2 Billion in Toronto IPO
Canadian healthcare company Apotex Health announced on Monday that it plans to raise up to C$1.2 billion through an initial public offering (IPO) on the Toronto Stock Exchange (TSX), marking one of the largest...